$1.38 0.00 (%) Navidea Biopharmaceuticals Inc - AMEX

Oct. 29, 2014 | 04:00 PM

Partner Headlines

  1. Navidea Joins Essex Woodland's Rheumco, Will Develop Radiopharmaceuticals To Detect And Treat Arthritic Diseases

    Benzinga | Jul. 16, 2014 | 07:32AM EST
  2. UPDATE: Navidea Biopharma Announces Positive Lymphoseek Injection Results

    Benzinga | Jun. 10, 2014 | 16:34PM EST
  3. Navidea Announces Presentation of Study Findings of Manocept Platform Imaging Agent in Kaposi Sarcoma at AACR Annual Meeting

    Benzinga | Apr. 10, 2014 | 07:31AM EST
  4. UPDATE: Navidea Biopharma Offers Update on EMA Application For Lymphoseek, Sets Second sNDA PDUFA Target Date Oct. 16th

    Benzinga | Mar. 19, 2014 | 17:33PM EST
  5. Morning Gainers for Mar. 6, 2014: PXLW, SGMO, ERII, RGSE, NAVB, PSTI

    Benzinga | Mar. 6, 2014 | 11:08AM EST
  6. Morning Movers for Mar. 5, 2014: FCEL, ARWR, SWHC, CPST Moving Higher

    Benzinga | Mar. 5, 2014 | 09:52AM EST
  7. Navidea Announces EMA Continues Marketing Authorization Application Review for Lymphoseek

    Benzinga | Dec. 19, 2013 | 19:34PM EST
  8. Stocks Hitting 52-Week Lows

    Benzinga | Oct. 29, 2013 | 11:23AM EST
  9. US Stock Futures Up Ahead Of Jobless Claims

    Benzinga | Aug. 22, 2013 | 07:21AM EST
  10. Navidea Biopharmaceuticals Announces Agreement with FDA on Special Protocol Assessments for NAV5001 Phase 3 Program

    Benzinga | Aug. 22, 2013 | 07:01AM EST
  11. Navidea to Collaborate with Maimonides Medical Center on Trial Utilizing Lymphoseek for Lymphatic Mapping in Colorectal Cancer

    Benzinga | Feb. 4, 2013 | 02:30AM EST
  12. UPDATE: Aegis Capital Initiates Navidea Biopharmaceuticals at Hold

    Benzinga | Jan. 22, 2013 | 03:09AM EST
  13. Navidea Biopharma Offers Interim Analysis Point of Phase 3 Head, Neck Cancer Study of Lymphoseek

    Benzinga | Jan. 3, 2013 | 02:05AM EST
  14. Navidea Submits Lymphoseek Marketing Application in Europe

    Benzinga | Dec. 18, 2012 | 02:32AM EST
  15. Navidea to Present Data from Lymphoseek Studies at RSNA, CTRC-AACR Meetings

    Benzinga | Nov. 26, 2012 | 03:23AM EST
  16. Navidea Biopharma Says PDUFA Goal Date for Lymphoseek April 30, 2013

    Benzinga | Nov. 13, 2012 | 09:31AM EST
  17. Navidea Biopharmaceuticals Announces the Presentation of Lymphoseek Data at Upcoming Scientific Meetings in October

    Benzinga | Oct. 10, 2012 | 08:23AM EST
  18. Morning Market Losers

    Benzinga | Sep. 11, 2012 | 03:55AM EST
  19. Benzinga's Top Pre-Market Losers

    Benzinga | Sep. 11, 2012 | 02:23AM EST
  20. Navidea Biopharmaceuticals Announces $50M Credit Facility with Platinum-Montaur Life Sciences

    Benzinga | Jul. 26, 2012 | 02:34AM EST
  21. Biotechs With Upcoming PDUFA Dates

    Benzinga | Jul. 18, 2012 | 09:09AM EST
  22. MModal, Unilever Among Stocks Up on High Volume Tuesday

    FoxBusiness | Jul. 3, 2012 | 06:32AM EST
  23. Meta-analysis of Navidea Biopharmaceuticals Lymphoseek® Phase 3 Data Compared to Standard of Care Techniques Published in Conjunction with the ASCO Annual Meeting

    Benzinga | Jun. 4, 2012 | 09:47AM EST
Trading Center